News

Lockheed Martin Corp. (NYSE: LMT) recently announced that its board of directors has authorized a third-quarter, 2025 ...
Following the U.S. House and Senate completing their work on the One Big Beautiful Bill Act — enacting much of President ...
Lockheed Martin Corp. (NYSE: LMT) has been awarded a $78.4 million modification to a previously awarded contract to exercise the option and provide ...
TissueCypher is a laboratory test that can help predict the risk of developing esophageal cancer in patients diagnosed with Barrett’s esophagus (BE).